Adipose tissue PCB levels and CYP1B1 and COMT genotypes in relation to breast cancer risk in postmenopausal Danish women

International Journal of Environmental Health Research

Volumn 24, Issue 3, 2014, Pages 256-268

  Bräuner, Elvira V ^a,b   Loft, Steffen ^c   Wellejus, Anja ^c   Autrup, Herman ^d   Tjønneland, Anne ^b   Raaschou Nielsen, Ole ^b  

^a AALBORG UNIVERSITY   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Breast cancer; PCBs; Polymorphisms

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1B1; POLYCHLORINATED BIPHENYL;

CANCER; CYTOCHROME; ESTROGENIC COMPOUND; ETIOLOGY; GENOTYPE; HORMONE; PCB; POLLUTION EXPOSURE; POLYMORPHISM; WOMENS HEALTH;

ADIPOSE TISSUE; ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

DENMARK;

ADIPOSE TISSUE; ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DATA INTERPRETATION, STATISTICAL; DENMARK; FEMALE; GENOTYPE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POLYCHLORINATED BIPHENYLS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK;

EID: 84898059557     PISSN: 09603123     EISSN: 13691619     Source Type: Journal    
DOI: 10.1080/09603123.2013.809703     Document Type: Article

References (32)

1. Adami HO, Lipworth L, Titus-Ernstoff L, Hsieh CC, Hanberg A, Ahlborg U, Baron J, Trichopoulos D. 1995. Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control. 6: 551-566.
2. Bräuner EV, Raaschou-Nielsen O, Gaudreau E, Leblanc A, Tjønneland A, Overvad K, Sørensen M. 2011. Predictors of polychlorinated biphenyl concentrations in adipose tissue in a general Danish population. Environ Sci Technol. 45: 679-685.
3. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. 2001. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res. 61: 6716-6722.
4. Dawling S, Roodi N, Parl FF. 2003. Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res. 63: 3127-3132.
5. Dawling S, Hachey DL, Roodi N, Parl FF. 2004. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Chem Res Toxicol. 17: 1258-1264.
6. De Vivo I, Hankinson SE, Li L, Colditz GA, Hunter DJ. 2002. Association of CYP1B1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 11: 489-492.
7. Gajjar K, Martin-Hirsch PL, Martin FL. 2012. CYP1B1 and hormone-induced cancer. Cancer Lett. 324: 13-30. doi: 10.1016/j.canlet.2012.04.021.
8. Garner CE, Burka LT, Etheridge AE, Matthews HB. 2000. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O- methyltransferase-mediated metabolism of catechol estrogens. Toxicol Appl Pharmacol. 162: 115-123.
9. Garner CE, Matthews HB, Burka LT. 2000. Phenolphthalein metabolite inhibits catechol-O-methyltransferase-mediated metabolism of catechol estrogens: a possible mechanism for carcinogenicity. Toxicol Appl Pharmacol. 162: 124-131.
10. GLOBOCAN. 2008. Cancer Fact Sheets, Breast Cancer Incidence and Mortality Worldwide in 2008. GLOBOCAN 2008 (IARC), Section of Cancer Information (10/6/2013); [cited 2012 June 22]. Available from: http://globocan.iarc.fr/ factsheets/cancers/breast.asp
11. Goodman JE, Jensen LT, He P, Yager JD. 2002. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics. 12: 517-528.
12. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. 2000. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 60: 3440-3444.
13. He XF, Wei W, Li SX, Su J, Zhang Y, Ye XH, Liu Y, Wang W. 2012. Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls. Mol Biol Rep. 39: 6811-6823. doi: 10.1007/s11033-012-1506-2.
14. Ho PW, Garner CE, Ho JW, Leung KC, Chu AC, Kwok KH, Kung MH, Burka LT, Ramsden DB, Ho SL. 2008. Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk. Curr Drug Metab. 9: 304-309.
15. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE. 2002. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol. 76: 643-649.
16. Kristensen VN, Borresen-Dale AL. 2000. Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism. Mutat Res. 462: 323-333.
17. Lee KM, Abel J, Ko Y, Harth V, Park WY, Seo JS, Yoo KY, Choi JY, Shin A, Ahn SH, et al. 2003. Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. Br J Cancer. 88: 675-678.
18. Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q. 2010. Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat. 121: 719-725.
19. Raaschou-Nielsen O, Pavuk M, Leblanc A, Dumas P, Philippe WJ, Olsen A, Tjønneland A, Overvad K, Olsen JH. 2005. Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women. Cancer Epidemiol Biomarkers Prev. 14: 67-74.
20. Ritter R, Scheringer M, MacLeod M, Moeckel C, Jones KC, Hungerbuhler K. 2010. Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the UK population. Environ Health Perspect. 119:225-231.
21. Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, Oscarson M, Ingelman-Sundberg M, Persson I. 2003. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk. Carcinogenesis. 24: 1533-1539.
22. Safe SH. 1997. Xenoestrogens and breast cancer. N Engl J Med. 337: 1303-1304.
23. Salehi F, Turner MC, Phillips KP, Wigle DT, Krewski D, Aronson KJ. 2008. Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J Toxicol Environ Health B Crit Rev. 11: 276-300.
24. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR. 1996. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56: 2979-2984.
25. Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam EM, Inoue K. 1999. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis. 20: 1607-1613.
26. Snedeker SM. 2001. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect. 109 (Suppl 1): 35-47.
27. Spink BC, Pang S, Pentecost BT, Spink DC. 2002. Induction of cytochrome P450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls. Toxicol In Vitro. 16: 695-704.
28. Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, et al. 2004. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 13: 94-101.
29. Vaclavik E, Tjønneland A, Stripp C, Overvad K, Philippe WJ, Raaschou-Nielsen O. 2006. Organochlorines in Danish women: predictors of adipose tissue concentrations. Environ Res. 100: 362-370.
30. Wen W, Cai Q, Shu XO, Cheng JR, Parl F, Pierce L, Gao YT, Zheng W. 2005. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. Cancer Epidemiol Biomarkers Prev. 14: 329-335.
31. Wolff MS, Camann D, Gammon M, Stellman SD. 1997. Proposed PCB congener groupings for epidemiological studies. Environ Health Perspect. 105: 13-14.
32. Zhu BT, Liehr JG. 1996. Inhibition of catechol O-methyltransferase- catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J Biol Chem. 271: 1357-1363.